StockWatch
·

Dodla Dairy Ltd

BSE: 543306

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
967.62
+12.0%+4.1%
Expenditure
938.31
+12.8%+9.8%
Net Profit
21.75
-60.8%-65.1%
OPM %
3.54%
-0.28pp-3.29pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00270.93541.87812.801.1KQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Record revenue, profit collapse: the pricing lag that defines the quarter

earnings · margin collapse · pricing lag

Result verdictFollow-upQ1 FY2702 Aug 20266 minFMCG

Revenue growth masks 35% PAT collapse; margin recovery depends on price-pass timing

margin compression · pricing lag · procurement inflation

TranscriptDeep diveQ1 FY2702 Aug 20266 minFMCG

Q1 FY27 Earnings: Where Growth Met Margin Pressure

Q1 FY27 · earnings · margin compression

ResearchDeep dive25 Jul 20266 minBanking
Latest
Board Meeting25 Jul, 11:00 am

Dodla margins crushed: consolidated PAT down 35% YoY to ₹41 Cr as milk costs surge

Dodla Dairy's Q1 FY27 consolidated revenue rose 19.0% YoY to ₹1,197.94 Cr, but net profit fell 35.4% to ₹40.64 Cr (and 41.7% sequentially from ₹69.73 Cr), with net margin compressing to 3.4% from 6.1% a year ago. There were no exceptional items on either side, so raw and adjusted YoY profit growth are identical — the decline is entirely operational. The headline topline is also flattered by consolidation of HR Food Processing (effective Aug 2025), which management itself flags renders the YoY numbers non-comparable; standalone revenue grew just 6.1% to ₹955.66 Cr. The squeeze sits squarely on the raw-material line: consolidated cost of materials consumed jumped ~32% YoY to ₹940.61 Cr, far outpacing the 19% revenue rise, reflecting elevated milk procurement prices. The pain is starkest in the core standalone India business, where PAT collapsed 65% YoY to ₹21.75 Cr; overseas subsidiaries (₹210.28 Cr revenue, ₹18.23 Cr net profit) plus HR Food cushioned the group figure. That leaves a ~30-point gap between standalone (-65%) and consolidated (-35%) profit trends — readers should note the consolidated print understates how hard domestic dairy was hit. On the Q4 FY26 concall management guided to low-to-mid-teens FY27 revenue growth with a 50-100 bps gross-margin recovery as procurement costs normalized. Q1 delivers the topline (reported +19%, though inorganic; standalone +6% at the low end of the 8-9% organic India target) but decisively misses on margins — procurement costs rose rather than eased, directly contradicting the recovery thesis. No published street consensus for the quarter was found. Alongside results the board approved a ~2% minority stake in premium antibiotic-free D2C brand Sids Farm (FY26 turnover ₹240 Cr) for ₹11.65 Cr cash from internal accruals — immaterial to financials but consistent with the stated 'selective acquisitions' stance and a foothold in premium/D2C dairy. The earnings call is set for 27 July 2026.

25 Jul 2026, 11:00 am

Corporate Events

Board MeetingDODLA
2026
25Jul

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing
Board MeetingDODLA
2026
14Jul

Board Meeting

The 31st Annual General Meeting of the Company will be held …

BSE Filing
DividendDODLA
2026
7Jul

₹5 / share

BSE Filing
DividendDODLA
2026
7Jul

₹5 / share

BSE Filing
Board MeetingDODLA
2026
16May

Board Meeting

The Board of Directors considered and approved the audited s…

BSE Filing
Board MeetingDODLA
2024
23Oct

Board Meeting

Consider and approve Unaudited standalone and consolidated f…

BSE Filing
Board MeetingDODLA
2024
18May

Board Meeting

Consider and approve Audited Standalone and Consolidated Fin…

BSE Filing
Board MeetingDODLA
2024
27Jan

Board Meeting

Consider and approve Un-Audited Standalone and Consolidated …

BSE Filing
Board MeetingDODLA
2023
21Oct

Board Meeting

Approval of Un-Audited Standalone and Consolidated Financial…

BSE Filing